Abstract
Complement-dependent cytotoxicity (CDC) mediated by a chimeric anti-Lewis Y monoclonal antibody (cH18A; human IgG1) was investigated in this study. Human lung adenocarcinoma cell lines (PC7, PC9, and PC14) were used as the target cells. PC7 and PC9 cells, expressed Lewis Y antigen and were lysed by cH18A as effectively as by the parent mouse anti-Lewis Y antibodies (mH18A) in a concentration-dependent manner. PC14 cells did not express Lewis Y antigen and were not lysed by either cH18A or mH18A. cH18A mediated CDC activity against PC7 and PC9 cells was enhanced by the combined use of monoclonal antibodies directed against CD46(MCP), CD55(DAF), and CD59. These molecules are complement-regulatory proteins which protect host cells from CDC. PC7 and PC9 cells, showed high levels of surface expression of these proteins, PC7 cells were more susceptible to cH18A-mediated CDC than PC9 cells. Use of multiple blocking antibodies to the complement-regulatory proteins produced more enhancement of cH18A-mediated CDC than a single antibody. Moreover, expression of CD55 and CD59 by PC7 and PC9 cells was decreased after treatment with PI-PLC, resulting in increased susceptibility to cH18A-mediated CDC. Although the reason is unknown, PC7 cells...Continue Reading
References
Nov 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D Solter, B B Knowles
Jun 1, 1992·The British Journal of Medical Psychology·A Roberts, J M Williams
Aug 1, 1991·European Journal of Immunology·M MatsumotoT Seya
Jan 2, 1992·International Journal of Cancer. Journal International Du Cancer·Y UraP P Major
Feb 1, 1992·British Journal of Cancer·M HosonoT Watanabe
Dec 1, 1990·The Journal of Experimental Medicine·T SeyaH Akedo
Jul 1, 1985·The Journal of Experimental Medicine·T KinoshitaV Nussenzweig
Apr 1, 1988·The Journal of Clinical Investigation·N K CheungM E Medof
Oct 1, 1988·Journal of Biochemistry·Y SugitaM Tomita
Jan 1, 1989·International Immunology·N OkadaH Okada
Aug 1, 1989·The Journal of Experimental Medicine·J V Ravetch, B Perussia
Mar 15, 1988·International Journal of Cancer. Journal International Du Cancer·K ZenitaR Kannagi
Sep 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N K CheungN A Berger
Aug 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·O F RamosJ Gergely
Apr 1, 1986·The Journal of Experimental Medicine·T SeyaJ P Atkinson
Jan 1, 1983·Immunogenetics·K O LloydK A Karlsson
Feb 1, 1983·Bioscience Reports·A BrownR W Baldwin
Jan 1, 1983·Annual Review of Medicine·R Levy, R A Miller
Nov 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S L MorrisonV T Oi
Dec 16, 1983·Journal of Immunological Methods·T Mosmann
Jun 1, 1981·The Journal of Experimental Medicine·H PerlmannH J Müller-Eberhard
Jul 1, 1993·Japanese Journal of Cancer Research : Gann·T SakumaY Mori
Oct 1, 1993·Clinical Immunology and Immunopathology·M HatanakaT Seya
Jan 1, 1995·The Journal of Experimental Medicine·M MatsumotoT Seya
Jan 1, 1993·Journal of Biochemistry·T KanekoK Yasukawa
Mar 1, 1993·The American Journal of Medicine·D M Goldenberg
Citations
Nov 10, 1998·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·L ThorsteinssonP M Johnson
Jun 21, 2006·Biochimica Et Biophysica Acta·Jan-Henrik MikeschBurkhard Brandt
Nov 9, 2000·European Journal of Immunology·L SpendloveL G Durrant
Apr 1, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·V T BlokA Gorter
Sep 21, 2017·Oncology Letters·Yu WangYan-Ping Wang
Apr 16, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Kyra A GeldermanArko Gorter